Serpil Savaş

BoNT-A Treatment Continuity and Patient- or Caregiver-Reported Reasons for Discontinuation or Irregular Continuation in Post-Stroke Spasticity: A Retrospective Cohort Study

ObjectiveThis study aimed to evaluate botulinum neurotoxintype A (BoNT-A) treatment continuity in patients withpost-stroke spasticity, to identify patient- or caregiver-reported reasons for treatment discontinuation or irregularcontinuation, and to examine the associationsbetween...